Klebsiella pneumonia is a rare, life-threatening bacterial infection, which has become increasingly prevalent in many countries. New research suggests that there may be new promises for a bioconjugate ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...